Scientific sessions

Home » Scientific Sessions

Scientific Session Day 1
Scientific Session Day 2
Scientific Session Day 3

Session 1Cancer Biology & Molecular Oncology

Cancer Biology & Molecular Oncology focuses on the cellular and molecular mechanisms that drive the development and progression of cancer. It explores how normal cells transform into malignant ones through genetic mutations, epigenetic changes, and abnormal signaling pathways. Key concepts include the roles of oncogenes, tumor suppressor genes, DNA repair defects, and the tumor microenvironment. Molecular oncology applies this knowledge to identify biomarkers and therapeutic targets, enabling the development of precision treatments like targeted therapy and immunotherapy. Advances in this field have improved early detection, prognosis, and individualized care. Together, cancer biology and molecular oncology form the foundation for modern cancer research and treatment.

Session 2Tumor Immunology & Immunotherapy

Tumor Immunology & Immunotherapy focuses on understanding how the immune system interacts with cancer and how it can be harnessed to fight tumors. Tumor immunology studies the ways in which cancer cells evade immune detection and suppress immune responses. Immunotherapy aims to boost or restore the immune system’s ability to recognize and destroy cancer cells. Key types include immune checkpoint inhibitors (e.g., PD-1, CTLA-4 blockers), CAR T-cell therapy, cancer vaccines, and monoclonal antibodies. These treatments have shown remarkable success in cancers like melanoma, lung cancer, and certain blood cancers. Immunotherapy represents a powerful and evolving strategy, offering durable responses and hope for long-term remission in many cancer patients.

Session 3Targeted Cancer Therapies

Targeted Cancer Therapies are treatments designed to specifically attack cancer cells by interfering with the molecules that drive tumor growth and survival. Unlike traditional chemotherapy, which affects both cancerous and healthy cells, targeted therapies focus on cancer-specific genes, proteins, or signaling pathways, minimizing damage to normal tissues. These therapies include monoclonal antibodies, tyrosine kinase inhibitors, and drugs that block angiogenesis or immune checkpoints. They are often guided by biomarker testing and genetic profiling to match the right treatment to the patient’s tumor characteristics. Targeted therapies have shown great success in cancers like breast, lung, and leukemia. This approach represents a key step toward more personalized and effective cancer care.

Session 4Cancer Genomics and Epigenetics

Cancer Genomics and Epigenetics explore how genetic and epigenetic changes drive the development and progression of cancer. Cancer genomics focuses on mutations, gene amplifications, deletions, and chromosomal rearrangements that alter the function of key oncogenes and tumor suppressor genes. These changes can be inherited or acquired and are critical for identifying molecular targets for therapy. Epigenetics, on the other hand, involves reversible modifications—such as DNA methylation and histone modification—that regulate gene expression without altering the DNA sequence. Abnormal epigenetic patterns can silence tumor suppressor genes or activate oncogenes. Together, genomics and epigenetics provide deeper insight into cancer biology and enable personalized treatments, early detection, and prognostic assessments.

Session 5Precision Medicine in Oncology

Precision Medicine in Oncology is a groundbreaking approach that tailors cancer treatment to the individual characteristics of each patient. It involves analyzing genetic, molecular, and environmental factors to understand the specific mutations driving a person’s cancer. By identifying these unique biomarkers, doctors can select targeted therapies that are more effective and less toxic than traditional treatments. Precision medicine also aids in predicting treatment response, monitoring disease progression, and reducing trial-and-error prescribing. Tools like genomic sequencing, liquid biopsy, and AI-powered data analysis have advanced this field significantly. Ultimately, precision oncology offers personalized, accurate, and efficient cancer care that improves patient outcomes.

Session 6Radiation Oncology & Cancer Imaging

Radiation Oncology & Cancer Imaging are critical components in the diagnosis, treatment, and monitoring of cancer. Radiation oncology uses high-energy radiation, such as X-rays or proton beams, to destroy cancer cells while sparing surrounding healthy tissue. It is used as a primary treatment, post-surgery, or in combination with chemotherapy. Advanced techniques like intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery improve precision and effectiveness. Cancer imaging—using MRI, CT scans, PET scans, and ultrasound—plays a key role in detecting tumors, guiding treatment, and assessing response. Innovations in imaging also help plan radiation delivery with high accuracy. Together, these fields enable more targeted, personalized, and effective cancer care.

Session 7Chemotherapy and Pharmacology

Chemotherapy and Pharmacology are central to the medical management of cancer, focusing on how drugs are used to destroy cancer cells and how these drugs interact within the body. Chemotherapy involves the use of cytotoxic agents that target rapidly dividing cells, aiming to shrink tumors, prevent metastasis, or eliminate residual cancer. Pharmacology studies how these drugs are absorbed, distributed, metabolized, and excreted, as well as their mechanisms of action and side effects. Advances in pharmacology have led to improved dosing strategies, combination therapies, and supportive medications to manage toxicity. Personalized chemotherapy, guided by pharmacogenomics, helps tailor treatment to individual patient profiles. Together, these fields strive to make cancer treatment more effective, safer, and patient-specific.

Session 8Cancer Stem Cells and Drug Resistance

Cancer Stem Cells and Drug Resistance explores how a small subset of cancer cells, known as cancer stem cells (CSCs), contribute to tumor growth, recurrence, and resistance to treatment. CSCs have the ability to self-renew, differentiate, and survive harsh conditions, including chemotherapy and radiation. Their unique properties allow them to evade traditional therapies, leading to relapse and metastasis. These cells are often found in protective tumor microenvironments that further shield them from drugs. Understanding the signaling pathways and molecular markers that sustain CSCs is crucial for developing targeted therapies. Combating CSCs holds the key to overcoming drug resistance and achieving long-term cancer remission.

Session 9Liquid Biopsy and Biomarker Discovery

Liquid Biopsy and Biomarker Discovery are transforming cancer diagnosis and monitoring through non-invasive, highly sensitive techniques. A liquid biopsy analyzes cancer-related materials—such as circulating tumor DNA (ctDNA), RNA, proteins, or exosomes—found in body fluids like blood, urine, or saliva. Unlike traditional biopsies, it poses minimal risk and can be performed repeatedly, allowing real-time monitoring of disease progression or treatment response. Biomarker discovery focuses on identifying measurable biological indicators that signal the presence or behavior of cancer. These biomarkers can aid in early detection, predict prognosis, and guide personalized therapies. Together, liquid biopsy and biomarker research are paving the way for more precise, timely, and patient-friendly cancer care.

Session 10Pediatric Oncology

Pediatric Oncology is the branch of medicine that focuses on the diagnosis and treatment of cancer in children, adolescents, and young adults. Common pediatric cancers include leukemia, brain tumors, neuroblastoma, and Wilms tumor. Unlike adult cancers, pediatric cancers are often the result of genetic changes rather than lifestyle or environmental factors. Symptoms can vary widely but may include unexplained weight loss, fatigue, pain, or swelling. Treatment typically involves a combination of chemotherapy, surgery, radiation, and increasingly, targeted therapies. Pediatric oncologists work closely with families to provide compassionate, child-centered care. Advances in research have significantly improved survival rates, but long-term follow-up is essential to manage potential side effects and support quality of life.

Session 11Hematologic Malignancies

Hematologic Malignancies are cancers that originate in the blood, bone marrow, and lymphatic system. They include leukemia, lymphoma, and multiple myeloma, each affecting different types of blood cells. These cancers often disrupt normal blood cell production, leading to symptoms like fatigue, infections, easy bruising, and swollen lymph nodes. Diagnosis involves blood tests, bone marrow biopsy, and imaging studies. Treatment options include chemotherapy, targeted therapy, immunotherapy, radiation, and bone marrow or stem cell transplantation. Advances in precision medicine have significantly improved outcomes, especially in certain subtypes like chronic myeloid leukemia. Ongoing research continues to develop more effective and less toxic therapies.

Session 12Breast Cancer: Diagnosis & Management

Breast Cancer: Diagnosis & Management focuses on the early detection, accurate diagnosis, and effective treatment of one of the most common cancers among women worldwide. Diagnosis typically involves clinical breast exams, mammography, ultrasound, MRI, and biopsy to confirm and stage the disease. Molecular testing helps identify hormone receptor status (ER, PR) and HER2 expression, which guide treatment choices. Management options include surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Early detection greatly improves prognosis and survival rates. Multidisciplinary care, including psychological support and rehabilitation, is essential for patient well-being. Ongoing research continues to advance personalized and less invasive treatment approaches.

Session 13Lung Cancer and Thoracic Oncology

Lung Cancer and Thoracic Oncology focus on cancers of the lungs and other organs in the chest, such as the esophagus, trachea, and mediastinum. Lung cancer is one of the leading causes of cancer-related deaths globally, with smoking being the primary risk factor, though non-smokers can also be affected. It is typically classified into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), each with different treatment approaches. Symptoms may include persistent cough, chest pain, shortness of breath, and weight loss. Diagnosis involves imaging (like CT scans), biopsies, and molecular testing. Advances in targeted therapies, immunotherapy, and minimally invasive surgery have improved survival rates. Thoracic oncology aims to provide comprehensive care through early detection, personalized treatment, and supportive care strategies.

Session 14Gastrointestinal Cancers

Gastrointestinal Cancers are a group of cancers that affect the digestive system, including the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers are among the most common and deadliest worldwide, often due to late diagnosis. Symptoms can include abdominal pain, weight loss, changes in bowel habits, or blood in the stool. Risk factors include smoking, alcohol use, poor diet, obesity, and infections like Helicobacter pylori and hepatitis viruses. Diagnosis involves endoscopy, imaging, biopsy, and tumor marker tests. Treatment options include surgery, chemotherapy, radiation, targeted therapy, and immunotherapy. Early detection and lifestyle changes play a crucial role in prevention and improved outcomes.

Session 15Prostate & Genitourinary Cancers

Prostate & Genitourinary Cancers refer to cancers that affect the male reproductive and urinary systems, including the prostate, bladder, kidneys, testicles, and urethra. Prostate cancer is the most common among them, often detected through PSA testing and digital rectal exams. Symptoms may include urinary difficulties, blood in urine, or pelvic pain, though early stages are often asymptomatic. Bladder and kidney cancers are commonly linked to smoking and environmental exposures. Treatment options vary by cancer type and stage and may include surgery, radiation, hormone therapy, immunotherapy, or targeted therapy. Early detection and regular screening are key to improving survival. Advances in precision medicine are offering more effective and individualized treatment approaches.

Session 16Gynecologic Oncology

Gynecologic Oncology is a specialized field focused on the diagnosis and treatment of cancers affecting the female reproductive system. This includes cancers of the ovary, uterus, cervix, vulva, and vagina. Early symptoms may include abnormal bleeding, pelvic pain, or bloating, and diagnosis often involves imaging, biopsies, and blood tests like CA-125. Treatment options typically include surgery, chemotherapy, radiation therapy, and increasingly, targeted and immunotherapies. Preventive measures, such as HPV vaccination and regular Pap smears, play a key role in reducing cervical cancer rates. Gynecologic oncologists provide both medical and emotional support to patients. The field continues to advance with research in early detection and personalized treatment strategies.

Session 17Neurological and Brain Tumors

Neurological and Brain Tumors refer to abnormal growths in the brain, spinal cord, or surrounding nerves, affecting the central nervous system. These tumors can be benign or malignant, with gliomas, meningiomas, and medulloblastomas among the most common types. Symptoms often include headaches, seizures, memory loss, or changes in behavior, depending on the tumor’s location. Diagnosis typically involves imaging techniques like MRI and CT scans, along with biopsy for confirmation. Treatment may include surgery, radiation therapy, chemotherapy, or targeted therapies. Due to their complex location, brain tumors pose unique challenges in treatment and recovery. Ongoing research focuses on improving outcomes through advanced surgical techniques, precision medicine, and immunotherapy.

Session 18Cancer Screening and Early Detection

Cancer Screening and Early Detection are critical strategies in reducing cancer mortality by identifying the disease at its earliest, most treatable stages. Screening tests—such as mammography for breast cancer, colonoscopy for colorectal cancer, and Pap smears for cervical cancer—can detect abnormalities before symptoms appear. Early detection allows for less aggressive treatments, improved survival rates, and better quality of life. Advances in imaging, blood-based biomarkers, and genetic testing are enhancing the accuracy and accessibility of screening. Public awareness and regular check-ups are essential for success. Effective screening programs save lives by catching cancer before it progresses.

Session 19Cancer Vaccines & Viral Oncology

Cancer Vaccines & Viral Oncology explores how viruses contribute to cancer and how vaccines can prevent or treat virus-related cancers. Certain viruses, such as human papillomavirus (HPV) and hepatitis B virus (HBV), are known to cause cancers like cervical and liver cancer. Preventive vaccines, like the HPV and HBV vaccines, have proven effective in reducing the incidence of these cancers. Therapeutic cancer vaccines aim to stimulate the immune system to recognize and attack existing cancer cells. Viral oncology also studies how viral infections lead to cellular changes that promote cancer development. Understanding these mechanisms helps in designing targeted treatments. This field plays a vital role in cancer prevention, immunotherapy, and global public health.

Session 20Artificial Intelligence in Cancer Diagnosis

Artificial Intelligence in Cancer Diagnosis is revolutionizing the way cancers are detected, analyzed, and treated. AI algorithms can rapidly process vast amounts of medical data, including imaging, pathology slides, and genomic information, to identify patterns that may be missed by human eyes. In radiology, AI helps detect tumors at earlier stages with greater accuracy through enhanced image analysis. In pathology, it assists in classifying cancer types and predicting prognosis. AI also supports personalized medicine by analyzing genetic profiles to guide treatment decisions. These technologies reduce diagnostic errors, speed up results, and improve overall clinical efficiency. As AI continues to evolve, it holds great promise for more accurate, timely, and personalized cancer care.

Session 21Robotic and Minimally Invasive Oncology

Robotic and Minimally Invasive Oncology represents a major advancement in cancer surgery and treatment. These techniques involve the use of robotic systems and small incisions to perform precise surgical procedures with minimal damage to healthy tissue. Robotic-assisted surgeries offer improved accuracy, reduced blood loss, shorter hospital stays, and faster recovery times. Minimally invasive methods are now used in treating cancers of the prostate, kidney, lung, and gastrointestinal tract, among others. Surgeons benefit from enhanced visualization and control, while patients experience fewer complications and better outcomes. These innovations are transforming cancer care by making treatments safer, less painful, and more effective.

Session 22Cancer Survivorship & Quality of Life

Cancer Survivorship & Quality of Life focuses on the health and well-being of individuals after cancer treatment. As survival rates improve, attention shifts to managing long-term physical, emotional, and social effects of cancer. Survivors may face fatigue, pain, cognitive changes, or risk of recurrence, requiring ongoing medical support and lifestyle adjustments. Psychosocial care is essential to address anxiety, depression, and the impact on relationships and work life. Rehabilitation, nutritional guidance, and physical activity programs help improve recovery and resilience. Survivorship care plans guide follow-up care and monitoring. Enhancing quality of life is now a key goal in comprehensive cancer care.

Session 23Clinical Trials and Translational Oncology

Clinical Trials and Translational Oncology bridge the gap between laboratory research and real-world cancer treatment. Translational oncology focuses on applying discoveries from basic science—such as new biomarkers or drug targets—into clinical applications. Clinical trials are essential for testing the safety, effectiveness, and optimal use of new cancer therapies in patients. These trials follow a phased process, from early safety assessments (Phase I) to large-scale efficacy studies (Phase III). They help validate targeted therapies, immunotherapies, and personalized medicine approaches. Patient participation in clinical trials also contributes to advancing cancer care globally. Together, these fields accelerate the development of innovative treatments and improve patient outcomes.

Session 24Cancer Metabolism and Microenvironment

Cancer Metabolism and Microenvironment examines how cancer cells alter their energy production and interact with their surrounding environment to survive and grow. Unlike normal cells, cancer cells often rely on glycolysis even in the presence of oxygen—a phenomenon known as the Warburg effect. This metabolic shift supports rapid cell division and tumor progression. The tumor microenvironment, which includes immune cells, blood vessels, fibroblasts, and extracellular matrix, plays a crucial role in cancer development and resistance to therapy. Interactions between cancer cells and their microenvironment influence inflammation, angiogenesis, and immune evasion. Understanding these processes helps in developing therapies that target cancer metabolism or disrupt the tumor-supportive environment. This field offers promising avenues for more effective and tailored cancer treatments.

Session 25Oncology Nursing and Patient Care

Oncology Nursing and Patient Care plays a vital role in supporting cancer patients through all stages of their treatment journey. Oncology nurses provide specialized care, including administering chemotherapy, managing side effects, and offering emotional support. They serve as key communicators between patients, families, and the medical team, ensuring coordinated and compassionate care. Patient education is also a core responsibility, helping individuals understand their diagnosis, treatment options, and self-care practices. Nurses monitor symptoms, manage pain, and support palliative care when needed. Their presence greatly improves patient comfort, adherence to treatment, and overall outcomes. Oncology nursing is essential for delivering holistic, patient-centered cancer care.

Session 26Nanotechnology in Cancer Therapy

Nanotechnology in Cancer Therapy is a cutting-edge field that uses nanoscale materials to improve cancer diagnosis, treatment, and drug delivery. Nanoparticles can be engineered to target cancer cells specifically, reducing damage to healthy tissues and minimizing side effects. They enhance the effectiveness of chemotherapy, radiotherapy, and immunotherapy by delivering drugs directly to tumor sites. Some nanoparticles are designed to release drugs in response to specific triggers like pH or temperature changes within the tumor. Nanotechnology also enables early detection through highly sensitive imaging and biosensors. Ongoing research aims to develop multifunctional nanocarriers for combined therapy and diagnostics (theranostics). This innovative approach is transforming cancer care with more precise and personalized treatments.

Session 27Environmental & Lifestyle Risk Factors

Environmental & Lifestyle Risk Factors play a significant role in the development and progression of cancer. Exposure to environmental pollutants, such as air pollution, radiation, and industrial chemicals, can increase cancer risk. Lifestyle choices like smoking, alcohol consumption, poor diet, lack of physical activity, and obesity are major contributors to several cancer types. Occupational hazards, such as asbestos and pesticide exposure, also pose serious risks. Additionally, prolonged sun exposure is linked to skin cancers like melanoma. Public health efforts focus on reducing these risks through education, regulations, and promoting healthy behaviors. Understanding and addressing these factors is essential for effective cancer prevention.

Session 28Natural Products and Herbal Oncology

Natural Products and Herbal Oncology focuses on the discovery and use of plant-based compounds in the fight against cancer. Many modern anticancer drugs, such as paclitaxel from the Pacific yew tree, originated from natural sources. Herbal remedies offer potential anti-cancer effects through mechanisms like apoptosis induction and inhibition of tumor growth. Traditional medicine systems, including Ayurveda and Traditional Chinese Medicine, provide a rich source of bioactive compounds. Scientific studies now aim to validate their safety, efficacy, and interactions with conventional therapies. These natural agents may also help reduce chemotherapy side effects and improve quality of life. Overall, this field blends traditional knowledge with modern science to support innovative cancer treatments.

Session 29Cancer Epidemiology and Public Health

Cancer Epidemiology and Public Health focuses on studying the patterns, causes, and effects of cancer in populations to inform effective prevention and control strategies. Epidemiologists analyze data on cancer incidence, mortality, and risk factors to identify trends and high-risk groups. This information guides public health policies, screening programs, and awareness campaigns. Key areas include the impact of lifestyle, environment, genetics, and social determinants on cancer risk. Public health efforts aim to reduce disparities in cancer outcomes through early detection, education, and access to care. Together, cancer epidemiology and public health play a vital role in reducing the global cancer burden and improving population health.

Session 30Advances in Cancer Prevention & Policy

Advances in Cancer Prevention & Policy focus on reducing cancer incidence through proactive strategies and effective regulations. Prevention includes lifestyle changes like tobacco cessation, healthy diets, vaccination (e.g., HPV, Hepatitis B), and regular screenings. Public health campaigns and education have raised awareness of modifiable cancer risk factors. Policy efforts now emphasize early detection programs, environmental safety regulations, and workplace exposure controls. Global frameworks, such as WHO’s cancer control strategy, guide national cancer prevention plans.